SHARPE·IQStart free
Menu
TodayResearchEarningsToolsPricingSign in
TWST reported Fiscal fourth quarter and full year 2026 results. The stock moved -6.8% on the print.
TWSTearnings

Earnings reactions, page 3

Twist Bioscience Corporation (TWST) Q4 FY2026 earnings

November 12, 2026 · SharpeIQ Research Desk

Reported results

  • Total revenue for fiscal 2026 was $459.4 million compared to $376.6 million for fiscal 2025 (GAAP).
  • Gross margin for fiscal 2026 was 52.4% compared to 50.7% for fiscal 2025 (GAAP).
  • Net loss for fiscal 2026 was $130.2 million, or $2.08 per diluted share, compared to $77.7 million, or $1.30 per diluted share, for fiscal 2025 (GAAP).
  • Adjusted EBITDA for fiscal 2026 was $(35.9) million compared to $(46.9) million for fiscal 2025 (non-GAAP).
  • Total revenue for the fourth quarter of fiscal 2026 was $126.6 million compared to $99.0 million for the same period of fiscal 2025 (GAAP).
  • Adjusted EBITDA for the fourth quarter of fiscal 2026 was $2.2 million compared to $(7.8) million for the same period of fiscal 2025 (non-GAAP).

Guidance

  • Fiscal 2027 total revenue in the range of approximately $550 million to $560 million.
  • Fiscal 2027 gross margin of approximately 52.5% to 53%.
  • Fiscal 2027 Adjusted EBITDA positive (non-GAAP).
  • Fiscal 2027 capital expenditures of approximately $75 million.
  • First quarter fiscal 2027 total revenue of approximately $130 million to $132 million.

Price and volatility reaction

The stock moved -6.8% on the print. No front-expiry chain was on file, so there is no straddle expected move.

MeasureValueBasis
Close before release122.592026-11-11
Close after release114.222026-11-12
Realised move-6.8%close to close
Price and volatility reaction. Closes either side of the release. No front-expiry chain on file for a straddle expected move. SharpeIQ — listed option chain and price_history

Source

The figures above come from the earnings release the company filed with the SEC on 2026-11-12 (8-K, Item 2.02). Read the original filing on sec.gov.

See this live in SharpeIQ

IV rank, historical IV and the single-ticker tools. The scanner and AI research are paid plans.

Open IV Rank →